ArticleCureus2026
Serum Uric Acid as a Biomarker of Disease Severity in Children With Complicated Malaria: A Cross-Sectional Study From Eastern India.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMalaria continues to be a significant contributor to morbidity among children in tropical countries. Increasing evidence suggests that elevated uric acid levels may reflect inflammatory activity and disease severity in malaria. The aim of this study was to measure serum uric acid (SUA) levels in children with complicated malaria and to examine their association with clinical outcomes and biochemical markers of hepatic dysfunction.
methodsA hospital-based cross-sectional investigation was carried out in the Pediatrics Department of a tertiary care teaching hospital in eastern India from 01/09/2022 to 31/05/2024. A total of 102 children aged 1-18 years with laboratory-confirmed complicated
resultsHyperuricemia was detected in 80.4% (82) of the participants. Elevated SGOT, SGPT, and bilirubin levels were observed in 72.5% (74), 83.3% (85), and 65.7% (67) of cases, respectively. Adverse outcomes occurred in 29.4% (30) of patients. Significant associations were found between adverse outcomes and abnormal SGOT (χ²=6.499, p=0.011), SGPT (χ²=8.500, p=0.004), and bilirubin (χ²=8.300, p=0.004), whereas SUA levels were not significantly associated with outcomes (p=0.115).
conclusionHyperuricemia is common in pediatric complicated malaria and may reflect infection-related inflammation. However, SUA alone may not reliably predict adverse clinical outcomes. Larger multicenter studies are needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.